Hims & Hers Health shares tumble over 3% as bearish technical signals outweigh upbeat revenue growth

Traders Union
All News
Stocks
Hims & hers health slides 3.11% today

Highlights

Hims & Hers Health reported a 38% year-over-year revenue increase and accelerated subscriber growth in the latest quarter.
The company expanded branded weight loss offerings, invested further in AI, and projects the Hers brand reaching a billion-dollar revenue segment by year-end.
Shares of Hims & Hers Health trade below key moving averages with bearish momentum signals, forecasting a $25.98 to $29.46 range and a 77% probability of a downward move over the next 5 days.

Subscriber surge and AI expansion amid persistent selling pressure

Hims & Hers Health marked its fifth anniversary as a public company with CEO Andrew Dudum participating in the NYSE opening bell ceremony. In the latest quarter, the company recorded a 38% year-over-year revenue increase and reported accelerated subscriber growth, attributed to its expanded branded weight loss offerings and adoption of AI-powered services. International expansion and continued investment in AI technology were reported, while the Hers brand was projected to reach a billion-dollar revenue segment by year-end. These operational highlights were accompanied by recent financial disclosures, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, notes the stock has decisively broken its bullish momentum despite recent upbeat numbers. He sees technical signals confirming a bearish phase, with Hims & Hers Health dropping below key averages and sellers dominating the session. Kharitonov points out that significant operational headlines and AI expansion have failed to sway sentiment in the short term, exposing the stock to further weakness. He warns that oversold readings, though noted, are not yet reliable for contrarian entries. "Current downside gaps and bearish indicators suggest traders should stay defensive and avoid premature bottom-fishing here."

Viktoras Karapetjanc, expert at Traders Union, views Hims & Hers Health as fundamentally strong. He highlights robust revenue growth of 38% and expanding AI-powered offerings as key value drivers. Karapetjanc sees the projected billion-dollar Hers brand and ongoing international expansion supporting future upside. He remains confident in the company's growth trajectory. "The bullish structure remains intact, and I expect further growth once the short-term volatility subsides."

Jainam Mehta, market strategist, notes the technical setup is clearly bearish with all major moving averages topped and momentum fading. He sees near-term support at $27.51 and resistance overhead at $29.46, defining a tactical range. Mehta believes sideways action is likely unless sellers gain conviction below the floor or buyers retake lost ground above resistance. "If intraday weakness persists, bears may press for a breakdown, but a quick reversal above $29.46 would signal tactical long opportunities."

Bearish momentum confirmed as technical boundaries signal persistent weakness

Hims & Hers Health currently trades below its 20-day, 50-day, and 200-day moving averages, with $27.72 versus $29.91, $31.75, and $29.17 respectively, indicating sustained pressure from sellers across short-, medium-, and long-term timeframes. The nearest levels to watch are the near-term ceiling at $27.73 and the floor at $27.51, with distant overhead resistance at the Ichimoku Kijun ($30.97) confirming a prevailing downtrend; the alignment of the 50-day and 200-day moving averages remains bullish for the long-term. Momentum signals are decisively bearish: MACD and Average Directional Index (ADX) indicate downward momentum, with MACD calling for further declines and a neutral ADX at 12.32 suggesting trend weakness. Relative Strength Index (RSI) at 44.19 and Commodity Channel Index (CCI) at -74.8 both issue sell signals, reflecting emerging oversold pressure, while Bull/Bear Power (BBP) at -1.14 shows sellers dominating intraday momentum and flags an "Oversold" forecast. The Awesome Oscillator (AO) reading at -2.87 reinforces the current selling pressure. The stock last traded at $27.72, down $0.89 or 3.11% for the session, opening with a downside gap of approximately 2.66% and currently trading near the session low. Intraday volatility stands at 3.86%, highlighting weakness and continued pressure after the open. Momentum and oscillator readings confirm the bearish tone.

Earlier, analysts noted that Hims & Hers Health was contending with persistent downside risk and technical resistance, signaling a cautious outlook for the stock. The latest data confirm this bearish technical structure, with the key actionable risk now centered on a potential breakdown toward $25.98 if the near-term floor fails to hold in the coming sessions.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.